ROCEPHIN

LOE Approaching

ceftriaxone sodium

NDAINTRAMUSCULAR, INTRAVENOUSINJECTABLEPriority Review
Approved
Dec 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT00230971Phase 4Completed

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Started Oct 2005
473 enrolled
AppendicitisCholecystitisDiverticulitis+3 more
NCT00195351Phase 4Completed

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection

Started Sep 2005
467 enrolled
AppendicitisCholecystitisCross Infection+2 more
NCT00540072Phase 3Completed

Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae

Started Jul 2001
Pneumonia, Bacterial
NCT00538694Phase 3Completed

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Started Oct 2000
Pneumonia, Bacterial
NCT00257049Phase 2/3Completed

A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia

Started Jan 1984
604 enrolled
Pneumonia